Dong-Kug Choi Selected Research

1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)

4/2022	Dioscin-Mediated Autophagy Alleviates MPP+-Induced Neuronal Degeneration: An In Vitro Parkinson's Disease Model.
10/2020	GPR4 Knockout Improves the Neurotoxin-Induced, Caspase-Dependent Mitochondrial Apoptosis of the Dopaminergic Neuronal Cell.
2/2017	Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson's Disease.
1/2013	Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model.
6/2011	Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells.
1/2011	A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Kug Choi Research Topics

Disease

34	Parkinson Disease (Parkinson's Disease) 04/2022 - 03/2002
28	Neuroinflammatory Diseases 01/2022 - 08/2006
17	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2002
13	Inflammation (Inflammations) 01/2021 - 04/2003
8	Cognitive Dysfunction 05/2021 - 01/2012
7	Neuroblastoma 04/2022 - 06/2003
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2012
5	Neoplasms (Cancer) 10/2020 - 09/2002
4	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2018
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2016
4	Chronic Disease (Chronic Diseases) 01/2018 - 01/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 04/2005
3	Hypoxia (Hypoxemia) 01/2016 - 01/2015
3	Gliosis 08/2013 - 04/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022 - 10/2020
2	Epilepsy (Aura) 01/2022 - 01/2019
2	Amnesia (Dissociative Amnesia) 05/2021 - 08/2017
2	Huntington Disease (Huntington's Disease) 01/2021 - 01/2005
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Brain Diseases (Brain Disorder) 01/2018 - 12/2016
2	Pain (Aches) 04/2015 - 01/2013
2	Hypokinesia (Bradykinesia) 04/2015 - 01/2013
2	Adenocarcinoma 10/2002 - 09/2002
1	Genomic Instability 01/2021
1	Pathologic Processes 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Stroke (Strokes) 01/2019
1	Infections 01/2018
1	Obesity 01/2018
1	Cicatrix (Scar) 01/2017

Drug/Important Bio-Agent (IBA)

15	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2021 - 03/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
9	CytokinesIBA 01/2021 - 01/2012
7	NeurotoxinsIBA 09/2016 - 04/2003
6	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 04/2022 - 01/2011
6	Pharmaceutical PreparationsIBA 01/2022 - 09/2016
6	AntioxidantsIBA 01/2021 - 01/2012
6	Biological ProductsIBA 01/2021 - 01/2014
5	Neuroprotective AgentsIBA 01/2022 - 01/2005
5	asaroneIBA 01/2022 - 01/2012
5	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2012
4	Scopolamine (Hyoscine)FDA Link 05/2021 - 08/2017
4	LipopolysaccharidesIBA 05/2021 - 04/2011
4	Cholinergic Agents (Cholinergics)IBA 07/2019 - 01/2012
4	NF-kappa B (NF-kB)IBA 01/2017 - 05/2010
3	Caspase 3 (Caspase-3)IBA 04/2022 - 12/2009
3	SynucleinsIBA 01/2022 - 01/2012
3	Oxygen (Dioxygen)IBA 01/2016 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 06/2015 - 12/2012
3	Free RadicalsIBA 09/2012 - 01/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 01/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2009 - 04/2003
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 01/2021
2	CaspasesIBA 04/2021 - 01/2021
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2021 - 01/2018
2	PhytochemicalsIBA 01/2021 - 01/2018
2	RotenoneIBA 01/2021 - 08/2011
2	gintoninIBA 01/2021 - 09/2018
2	LipidsIBA 01/2020 - 10/2018
2	Lipid NanoparticlesIBA 03/2019 - 01/2018
2	Taurine FDA Link 01/2019 - 01/2015
2	IronIBA 01/2016 - 01/2012
2	CannabinoidsIBA 04/2015 - 01/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014 - 01/2003
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2012 - 12/2009
2	EnzymesIBA 01/2012 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 08/2007
2	OsteonectinIBA 10/2002 - 09/2002
1	dioscinIBA 04/2022
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2021
1	4-trifluoromethylsalicylic acid (HTB)IBA 11/2020
1	AnhydridesIBA 11/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2019
1	QuercetinIBA 10/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2019
1	CurcuminIBA 03/2019
1	PolyphenolsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	irilin BIBA 01/2019
1	ChemokinesIBA 10/2018
1	GinsenosidesIBA 09/2018
1	Liposomes (Liposome)IBA 09/2018
1	ginsenoside M1IBA 09/2018
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	thymoquinoneIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	atractylenolide IIBA 05/2017
1	ErbB Receptors (EGF Receptor)IBA 02/2017
1	Retinaldehyde (Retinal)IBA 01/2017

Therapy/Procedure

8	Therapeutics 04/2022 - 04/2015
2	Oral Administration 11/2020 - 07/2019
2	East Asian Traditional Medicine (Oriental Medicine) 04/2015 - 11/2013